Remembering Kathy Brandt: Hospice and Palliative Care Advocate
by Christian Sinclair (@ctsinclair)As some of you may already now, we lost a great voice and energy in our field of palliative care and hospice yesterday, August 4th, when Kathy Brandt died at home with her wife,Kimberly Acquaviva and son, Greyson. Kathy was diagnosed with ovarian cancer in January of 2019. Kathy most recently worked on the National Consensus Project Guidelines, 4th edition, as the writer and editor, which was released in 2018. She had over 30 years experience in the aging and end-of-life issues and was helpful to many organizations as theprincipal and founder of the kb group.In addition to all that work over the past 30 years, her most lasting impact is likely to beher own narrative, which she shared online with all of us. Through Kathy's social media posts and theinsight of Kim and Greyson as they walked her journey with her, we have been able to follow along and see the ups and downs of serious illness and end of life.I was able to work alongside Kathy in a few instances and she always had the energy, wit and insight to improve the situation and manage the project. I will miss her greatly, and I know a lot of you will too. I hope that we can all find a way to include her in the work we do and remember the contributions she made to promoting excellence in the work that we do.We can all probably help a little by contributing to their GoFundMe. I'm sure we can get it over $100,000. It is at $81,842 right now.
CONCLUSION: The quality of studies was relatively low, however the evidence shows that non-surgical management of bowel obstruction results in a short life expectancy but with controlled symptoms. Where quality of life is the main concern, this may be a feasible and effective strategy.PMID:34490792 | DOI:10.1177/10499091211043079
CONCLUSIONS: This study developed and validated the MOST-S26, for surveillance of women in follow-up after first-line chemotherapy for OC. MOST-S26 reliably detected improvement in symptoms of peripheral neuropathy, psychological distress and may detect symptoms of relapse. Administration of MOST-S26 in follow-up consultations could identify concerning symptoms and facilitate timely and appropriate intervention.PMID:34481610 | DOI:10.1016/j.ygyno.2021.08.022
Radiation therapy (RT) is increasingly being used in gynecological cancer management. RT delivered with curative or palliative intent can be administered alone or combined with chemotherapy or surgery. Advanced treatment planning and delivery techniques such as intensity-modulated radiation therapy, including volumetric modulated arc therapy, and image-guided adaptive brachytherapy allow for highly conformal radiation dose delivery leading to improved tumor control rates and less treatment toxicity. Quality on-board imaging that provides accurate visualization of target and surrounding organs at risk is a critical feature ...
ConclusionOur study provides new insights into breast and ovarian cancer genetic landscape in the under-represented North African populations. The prevalence assessment of novel and recurrent BRCA1/2 pathogenic mutations will enhance the use of personalized treatment and precise screening strategies by both affected and unaffected North African cancer cases.
ConclusionsFor patients with suspected ovarian cancer, the incidence of gastrointestinal metastases is low, routine gastroscopy/colonoscopy before treatment is less efficient. Gastroscopy/colonoscopy has limited power to predict the need for gastrointestinal resection before ovarian cancer surgery.
According to this study: Many women who have ovarian cancer still receive aggressive end-of-life care despite recommendations emphasizing early palliative care.Nonwhite women are more likely to receive aggressive care.PMID:34156383 | DOI:10.1097/01.NAJ.0000758516.82836.d5